Novo Nordisk Executive Collapses in Oval Office
On Thursday afternoon, Gordon Findlay, an executive from Novo Nordisk, collapsed in the Oval Office while President Trump was announcing a plan aimed at lowering the cost of weight-loss medications, including Ozempic.
Findlay received immediate assistance and was helped to his feet. Medical support was provided on the spot, and he is expected to recover fully.
Event Details
- Incident occurred during the announcement of a drug price reduction plan by President Trump.
- The affected executive is Gordon Findlay of Novo Nordisk.
- Drugs involved in the price reduction plan include Ozempic, a weight-loss medication.
- Findlay was medically assisted promptly and is anticipated to be fine.
Related Coverage
- Health news involving Novo Nordisk executives
- Video footage capturing the collapse
- Updates on weight-loss drug pricing and policies
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
Reported by Web Editor Jodi Leese Glusco, November 6, 2025.
Summary
This incident highlights the intense atmosphere in the Oval Office during significant policy announcements, underscoring the human side of high-level healthcare discussions.
Would you like the summary to be more formal or casual?